N-acetylprocainamide

Independent reference data for N-acetylprocainamide (CAS 32795-44-1), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
• Acecainide is a known human metabolite of Procainamide.

Synonyms and trade names

N-Acetylprocainamide; Acecainide; 32795-44-1; Acecainida; Acekainid; Acecainidum; N-Acetyloprokainamid; Acetylprocainamide; N-acetylnovocainamide; N-Acetylprocaine amide; 4'-((2-(Diethylamino)ethyl)carbamoyl)acetanilide; n-acetyl-procainamide; Acetylprocainamide, n-; Benzamide, 4-(acetylamino)-N-(2-(diethylamino)ethyl)-; CHEBI:60728; 910Q707V6F

GHS hazard classification

What the public record says

N-acetylprocainamide · CAS 32795-44-1 · C15H23N3O2. UNII 910Q707V6F.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.